Cargando…
Genetic markers of artemisinin resistance in Plasmodium spp. parasites
The vast majority of malaria patients worldwide are currently treated with combination therapy comprising one of the artemisinin family of drugs, characterised by rapid action and short plasma half-life, co-formulated with a longer-lasting drug from the amino aryl-alcohol or quinoline families. Ther...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Portland Press Ltd.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288991/ https://www.ncbi.nlm.nih.gov/pubmed/33525848 http://dx.doi.org/10.1042/ETLS20170100 |